Skip to main navigation Skip to search Skip to main content

The Future of Obesity Care: Exploring Synergies Between Metabolic Bariatric Surgery, Interventional Endoscopy and Pharmacotherapy

  • Wendy A Brown
  • , Priya Sumithran
  • , Michael Cowley
  • , Ricardo Cohen
  • , Carel Le Roux
  • , Philip Schauer
  • , Santosh Agarwal
  • , Jamie Ard
  • , Camilo Boza
  • , Jenny Lynn Cargiuolo
  • , Letizia Ceccarelli
  • , Jake Coverdale
  • , Brian Dunkin
  • , Francis Finucane
  • , Kapil Gupta
  • , Lee M Kaplan
  • , Marina Kurian
  • , Ildiko Lingvay
  • , Alex Miras
  • , Chuck Pearlman
  • Terissa Petry, Dimitri Pournaras, Jonthan Purnell, Roxana Ruiz, Carlos Schiavon, Abd Tahrani, Hanan Tarek, Jorg Tomaszewski, Sascha Tumik, Ramy Younes

Research output: Contribution to journalArticlepeer-review

4 Downloads (Pure)

Abstract

With the advent of new effective treatments for obesity, the field is rapidly changing creating an urgent need for evidence to guide best patient management. To help prioritise and plan for future trials, a meeting of experts was convened with the aim of reviewing the current literature to identify and prioritise current knowledge gaps; identify relevant research questions, and discuss appropriate trial methodologies that could be utilised to address the identified gaps in a timely and pragmatic manner. Participants included research-active academic surgeons and physicians, and industry representatives from various pharmaceutical and device companies. This report summarizes the key outcomes from this meeting.
Original languageEnglish
Pages (from-to)3326-3337
Number of pages12
JournalObesity Surgery
Volume36
Issue number6
Early online date4 May 2026
DOIs
Publication statusPublished (in print/issue) - 30 Jun 2026

Bibliographical note

© The Author(s) 2026.

Data Availability Statement

No datasets were generated or analysed during the current study.

Funding

Open Access funding enabled and organized by CAUL and its Member Institutions. The meeting which informed this paper was covered fully by registration fees. All participants paid a registration fee to attend this meeting with industry attendees (Boehringher-Ingelheim, Boston Scientific, Eli Lilly, Johnson and Johnson, Medtronic, Novo Nordisc, WL Gore) paying a higher registration than clinician and academic attendees. No financial support was received for the production of this paper.

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'The Future of Obesity Care: Exploring Synergies Between Metabolic Bariatric Surgery, Interventional Endoscopy and Pharmacotherapy'. Together they form a unique fingerprint.

    Cite this